Status:
COMPLETED
Topical Versus Oral Metronidazole Following Excisional Haemorrhoidectomy
Lead Sponsor:
University of Auckland, New Zealand
Conditions:
Hemorrhoids
Postoperative Pain
Eligibility:
All Genders
16+ years
Phase:
PHASE4
Brief Summary
This study aims to determine if topical metronidazole reduces pain more than oral metronidazole following excisional haemorrhoidectomy. The trial will be a multi-centered, patient and investigator bli...
Detailed Description
The pathogenesis of post-operative excisional haemorrhoidectomy pain is multi-factorial with secondary bacterial colonisation, inflammation and anal sphincter spasm/hypertonicity all purposed to play ...
Eligibility Criteria
Inclusion
- All patients undergoing excisional haemorrhoidectomy
Exclusion
- \< 16 years of age
- Have a simultaneous operation other than excisional haemorrhoidectomy
- History of chronic pain
- Previous allergy/adverse reaction to metronidazole
- Patients unable to consent or complete data questionnaires due to cognitive impairment
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03343509
Start Date
March 11 2019
End Date
February 1 2020
Last Update
November 3 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Manukau SuperClinic, Counties Manukau District Health Board
Auckland, New Zealand
2
Ormiston Hospital
Auckland, New Zealand